9,10-dimethyl-1,2-benzanthracene has been researched along with indomethacin in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (46.43) | 18.7374 |
| 1990's | 8 (28.57) | 18.2507 |
| 2000's | 4 (14.29) | 29.6817 |
| 2010's | 3 (10.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shoyab, M | 1 |
| Miyazaki, I; Mizukami, Y; Nakamura, S; Noguchi, M; Nonomura, A; Taniya, T; Thomas, M | 1 |
| Tabara, M; Watanabe, M | 1 |
| Andrews, FJ; Halliday, GM; Muller, HK; Narkowicz, CK | 1 |
| Koyasaki, N; Kumaki, T; Miyazaki, I; Mizukami, Y; Noguchi, M; Taniya, T | 1 |
| Andrews, J; Halliday, GM; Muller, HK | 1 |
| Fischer, SM; Patamalai, B; Patrick, KE; Slaga, TJ | 1 |
| Quere, P; Thorbecke, GJ; Tsiagbe, VK | 1 |
| Carter, CA; Ip, C; Ip, MM | 1 |
| Abou-el-Ela, SH; Bunce, OR; Carroll, RW; Farrell, RL; Prasse, KW; Wade, AE | 1 |
| Abe, S | 1 |
| Boutwell, RK; Cleaveland, JS; Ordman, AB; Simsiman, RC | 1 |
| McCormick, DL; Wilson, AM | 1 |
| Craig, GT; Franklin, CD | 1 |
| Madigan, MJ; McCormick, DL; Moon, RC | 1 |
| Gould, AR; Grant, FT; Miller, RL; Perry, DA | 1 |
| Carter, CA; Ip, MM; Milholland, RJ; Shea, W | 1 |
| Boutwell, RK | 1 |
| Perkins, TM; Shklar, G | 1 |
| Ashendel, CL; Astrup, E; Boutwell, RK; Verma, AK | 1 |
| Jiang, H; Kato, R; Yamamoto, S | 1 |
| Horio, T; Kuwamoto, K; Miyauchi-Hashimoto, H; Tanaka, K; Urade, Y | 1 |
| Adámeková, E; Ahlers, I; Ahlersová, E; Bojková, B; Kubatka, P; M ciková-Kalická, K; Mníchová-Chamilová, M | 1 |
| Chang, YC; Joo, ST; Kim, CH; Park, KK; Park, WH | 1 |
| Fujimoto, Y; Iida, T; Yasukawa, K | 1 |
| Sanyal, SN; Setia, S; Vaish, V | 1 |
| Sanyal, SN; Setia, S | 2 |
1 review(s) available for 9,10-dimethyl-1,2-benzanthracene and indomethacin
| Article | Year |
|---|---|
Mouse skin: a useful model system for studying the mechanism of chemical carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkylating Agents; Animals; Carcinogens; Cell Communication; Cell Differentiation; Cell Division; Cocarcinogenesis; DNA; Indomethacin; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; Polyamines; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin | 1982 |
27 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and indomethacin
| Article | Year |
|---|---|
Effects of prostaglandins and some anti-inflammatory drugs on the binding of 7,12-dimethylbenz[alpha]anthracene to the DNA of murine epidermal cells in culture.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Aspirin; Benz(a)Anthracenes; Cells, Cultured; DNA; Flufenamic Acid; Fluocinolone Acetonide; Indomethacin; Mice; Prostaglandins E, Synthetic; Prostaglandins F, Synthetic; Skin | 1979 |
Effects of high and low dietary fat and indomethacin on tumour growth, hormone receptor status and growth factor expression in DMBA-induced rat breast cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Bromodeoxyuridine; Cell Division; Dietary Fats, Unsaturated; Female; Growth Substances; Immunohistochemistry; Incidence; Indomethacin; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone | 1992 |
Abrogation of the suppressive effect of 12-O-tetradecanoylphorbol 13-acetate and 7,12-dimethylbenz[a]anthracene on footpad reaction of mice by indomethacin and some inhibitors of tumor promotion.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Drug Interactions; Hypersensitivity, Delayed; Indomethacin; Male; Mice; Mice, Inbred BALB C; Tetradecanoylphorbol Acetate | 1992 |
Indomethacin inhibits the chemical carcinogen benzo(a)pyrene but not dimethylbenz(a)anthracene from altering Langerhans cell distribution and morphology.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benzo(a)pyrene; Cell Count; Dinoprostone; Drug Implants; Indomethacin; Langerhans Cells; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron; Skin | 1991 |
Effects of the prostaglandin synthetase inhibitor indomethacin on tumorigenesis, tumor proliferation, cell kinetics, and receptor contents of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in Sprague-Dawley rats fed a high- or low-fat diet.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Cell Cycle; Cell Division; Cyclooxygenase Inhibitors; Dietary Fats; DNA, Neoplasm; Female; Flow Cytometry; Indomethacin; Kinetics; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 1991 |
A role for prostaglandins in the suppression of cutaneous cellular immunity and tumour development in benzo(a)pyrene- but not dimethylbenz(a)anthracene-treated mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Presenting Cells; Benzo(a)pyrene; Carcinoma, Squamous Cell; Dermatitis, Contact; Dinitrobenzenes; Immunity, Cellular; Indomethacin; Male; Mice; Mice, Inbred BALB C; Skin; Skin Neoplasms | 1991 |
Effects of antihistamines on phorbol ester tumor promotion and vascular permeability changes.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Capillary Permeability; Cimetidine; Diphenhydramine; Female; Indomethacin; Inflammation; Masoprocol; Mice; Mice, Inbred Strains; Papilloma; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1990 |
Proliferative response of T cells from tumor-immune chickens to carcinogen-induced fibrosarcoma cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Division; Cell Line; Chickens; Cross Reactions; Fibrosarcoma; Gamma Rays; Immunity, Cellular; Immunization; Indomethacin; Neoplasm Transplantation; Spleen; T-Lymphocytes | 1990 |
A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cell Transformation, Neoplastic; Dietary Fats; Fatty Acids, Essential; Female; Indomethacin; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Prostaglandin Antagonists; Prostaglandins E; Rats; Rats, Inbred Strains | 1989 |
Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Dietary Fats; Eflornithine; Female; Indomethacin; Leukotriene B4; Mammary Neoplasms, Experimental; Ornithine Decarboxylase; Prostaglandins E; Rats; Rats, Inbred Strains | 1989 |
Effects of arachidonic acid and indomethacin on sister-chromatid exchange induction by polycyclic aromatic hydrocarbons in mammalian cell lines.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Arachidonic Acid; Arachidonic Acids; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Carcinoma, Hepatocellular; Cell Line; Cricetinae; Cricetulus; Drug Synergism; Enzyme Induction; Humans; Indomethacin; Liver Neoplasms; Rats; Sister Chromatid Exchange | 1986 |
The role of prostaglandin E1 in ornithine decarboxylase induction by tumor promoters.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alprostadil; Animals; Diterpenes; Enzyme Induction; Female; Indomethacin; Mice; Mice, Inbred Strains; Models, Biological; Neoplasms; Ornithine Decarboxylase; Phorbols; Terpenes; Tetradecanoylphorbol Acetate; Tretinoin | 1986 |
Combination chemoprevention of rat mammary carcinogenesis by indomethacin and butylated hydroxytoluene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Butylated Hydroxytoluene; Dose-Response Relationship, Drug; Female; Indomethacin; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains | 1986 |
The effect of indomethacin on tumor regression in DMBA-induced epithelial neoplasia of hamster cheek pouch mucosa.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cheek; Cricetinae; Indomethacin; Lymph Nodes; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms | 1987 |
Modulation of rat mammary carcinogenesis by indomethacin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animal Feed; Animals; Dose-Response Relationship, Drug; Female; Indomethacin; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains | 1985 |
Indomethacin and 7,12-dimethylbenz(a)anthracene-induced carcinogenesis in the hamster buccal pouch.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma; Cheek; Cricetinae; Dinitrochlorobenzene; Drug Hypersensitivity; Foot; Hindlimb; Hypersensitivity, Delayed; Indomethacin; Male; Mesocricetus; Mouth Neoplasms; Neoplasms, Experimental | 1985 |
Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Body Weight; Corticosterone; Cyclooxygenase Inhibitors; Dietary Fats; Female; Indomethacin; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains | 1983 |
On the role of tumour promotion in chemical carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Dexamethasone; DNA Replication; Hyperplasia; Indomethacin; Mice; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin | 1984 |
Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Aspirin; Carcinoma, Squamous Cell; Cheek; Cricetinae; Female; Indomethacin; Male; Mesocricetus; Mouth Neoplasms; Neoplasms, Experimental; Time Factors | 1982 |
Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Administration, Topical; Animals; Anticarcinogenic Agents; Arachidonate Lipoxygenases; Benzo(a)pyrene; Female; Indomethacin; Lipoxygenase Inhibitors; Mice; Mice, Inbred Strains; Piperidines; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1994 |
Carcinogen-induced inflammation and immunosuppression are enhanced in xeroderma pigmentosum group A model mice associated with hyperproduction of prostaglandin E2.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adjuvants, Immunologic; Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apyrase; Carcinogens; Dermatitis, Contact; Dinitrofluorobenzene; Dinoprostone; Disease Models, Animal; DNA-Binding Proteins; Ear; Edema; Female; Immunosuppressive Agents; Indomethacin; Inflammation; Interleukin-10; Langerhans Cells; Mice; Mice, Hairless; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Skin; Tumor Necrosis Factor-alpha; Up-Regulation; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group A Protein | 2001 |
Preventive effect of indomethacin and melatonin on 7, 12-dimethybenz/a/anthracene-induced mammary carcinogenesis in female Sprague-Dawley rats. A preliminary report.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Female; Indomethacin; Mammary Neoplasms, Experimental; Melatonin; Rats; Rats, Sprague-Dawley | 2001 |
Effects of the Geiji-Bokryung-Hwan on carrageenan-induced inflammation in mice and cyclooxygenase-2 in hepatoma cells of HepG2 and Hep3B.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Hepatocellular; Carrageenan; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Edema; Female; Hindlimb; Humans; Hydroquinones; Indomethacin; Inflammation; Isoenzymes; Liver Neoplasms; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Phenylbutazone; Plant Extracts; Prostaglandin-Endoperoxide Synthases; Protein-Tyrosine Kinases; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tyrphostins | 2004 |
Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Bile Acids and Salts; Carcinogens; Chenodeoxycholic Acid; Disease Models, Animal; Edema; Female; Indomethacin; Inflammation; Inhibitory Concentration 50; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Skin Neoplasms; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 2009 |
Chemopreventive effects of NSAIDs as inhibitors of cyclooxygenase-2 and inducers of apoptosis in experimental lung carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bronchoalveolar Lavage Fluid; Carcinoma, Non-Small-Cell Lung; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; DNA Fragmentation; Drug Screening Assays, Antitumor; Etoricoxib; Female; Indomethacin; Lung; Lung Neoplasms; Membrane Proteins; Neoplasms, Experimental; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Sulfones; Tumor Burden | 2012 |
Nuclear factor kappa B: a pro-inflammatory, transcription factor-mediated signalling pathway in lung carcinogenesis and its inhibition by nonsteroidal anti-inflammatory drugs.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Proliferation; Chemoprevention; Disease Models, Animal; Etoricoxib; Indomethacin; Lung Neoplasms; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Pyridines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sulfones; Transcription Factors | 2012 |
Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; DNA Fragmentation; Etoricoxib; Female; Indomethacin; Lung Neoplasms; Pyridines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Sulfones; Up-Regulation | 2012 |